INVOS-Brand-Image

Backed by extensive clinical research and the Covidien commitment to ongoing technology development, the INVOS™ system remains the market leader in regional oximetry.

With more than 800 unique clinical references, the INVOS™ system is the referenced standard in clinical academia and the medical device industry. Users of the INVOS system gain the confidence that comes with a technology proven to make a positive clinical impact and known to set the standard in regional oximetry.

Featured Categories

Improving Patient Outcomes

Improving Patient Outcomes

The INVOS™ system provides real-time rSO2 mapping that helps nurses and doctors detect and correct ischemic problems before they lead to complications and poor outcomes.

[ View Brochure ]

Designed to Treat a Range of Complex Patients

Designed to Treat a Range of Complex Patients

Designed to Treat a Range of Complex Patients

[ View Info Sheet ]

The INVOS Technology Difference

The INVOS™ Technology Difference

The INVOS™ system offers the only cerebral/somatic oximeter backed by an improved patient outcomes claim.1,2,3

[ View Info Sheet ]

Kampine Video

View a clinical perspective NIRS in perioperative pediatric anesthesia.

Dr. John M. Kampine discusses the INVOS™ system in regional circulation monitoring.

[ View Video ]

Raymond Video

Learn about NIRS monitoring in a congenital heart ICU environment.

Dr. Tia Raymond shares her views on monitoring pediatric cardiac surgery patients with the INVOS™ system.

[ View Video ]

Related INVOS™ Products

  1. Murkin JM, et al. Anesth Analg. 2007 Jan;104(1):51-8.
  2. Casati A, et al. Anesth Analg. 2005 Sep;101(3):740-7.
  3. http://www.accessdata.fda.gov/cdrh_docs/pdf8/K082327.pdf